NCT06294639

ED50 of Esketamine for Laser Treatment in Children

Median Effective Dose (ED50) of Esketamine Combined With Alfentanil for Children to Inhibit Body Movement During Laser Treatment for Facial Lesion

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Air Force Military Medical University, China · Academic / Other
• Sex: All
• Age: 3 Years – 12 Years
• Healthy volunteers: Not accepted

Summary

There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.

Conditions

• Anesthesia

Interventions

Type	Name	Description
DRUG	Esketamine	esketamine will be given intravenously

Timeline

• Start date: 2024-03-27
• Primary completion: 2025-03-27
• Completion: 2025-04-27
• First posted: 2024-03-05
• Last updated: 2024-03-05